University of Torino, Torino, Italy.
Hospital Universitari Mutua Terrassa, Terrassa, Spain; Network of Centers for Biomedical Research in Respiratory Diseases (CIBERES) Lung Cancer Group, Terrassa, Spain.
J Thorac Oncol. 2022 Jun;17(6):838-851. doi: 10.1016/j.jtho.2022.03.005. Epub 2022 Mar 20.
Thymic epithelial tumors are presently staged using a consistent TNM classification developed by the International Association for the Study of Lung Cancer (IASLC) and approved by the Union for International Cancer Control and the American Joint Committee on Cancer. The stage classification is incorporated in the eight edition of the TNM classification of thoracic malignancies. The IASLC Staging and Prognostic Factors Committee (SPFC)-Thymic Domain (TD) is in charge for the next (ninth) edition expected in 2024. The present article represents the midterm report of the SPFC-TD: in particular, it describes the unresolved issues identified by the group in the current stage classification which are worth being addressed and discussed for the ninth edition of the TNM classification on the basis of the available data collected in the central thymic database which will be managed and analyzed by Cancer Research And Biostatistics. These issues are grouped into issues of general importance and those specifically related to T, N, and M categories. Each issue is described in reference to the most recent reports on the subject, and the priority assigned by the IASLC SPFC-TD for the discussion of the ninth edition is provided.
胸腺上皮肿瘤目前采用国际肺癌研究协会 (IASLC) 制定并经国际癌症控制联盟和美国癌症联合委员会批准的一致 TNM 分类进行分期。该分期分类被纳入了第八版胸内恶性肿瘤的 TNM 分类。IASLC 分期和预后因素委员会 (SPFC)-胸腺域 (TD) 负责 2024 年预计的下一个 (第九版) 版本。本文代表 SPFC-TD 的中期报告:特别是,它描述了该小组在当前分期分类中发现的未解决问题,这些问题值得根据中央胸腺数据库中收集的现有数据进行讨论,该数据库将由癌症研究和生物统计学进行管理和分析。这些问题分为普遍重要的问题和与 T、N 和 M 类别具体相关的问题。每个问题都参考了关于该主题的最新报告,并提供了 IASLC SPFC-TD 为讨论第九版分配的优先级。